TABLE 2

Correlation of 111In-Ibritumomab Pretherapy Scans and Outcomes of 90Y-Ibritumomab Therapy in Studied Population

Pretherapy scan findings
OutcomePositiveNegative
Complete response (9/28)27
Partial response (8/28)71
Mixed response (4/28)40
No change (4/28)31
Progressive disease (3/28)30
  • Data are numbers of patients with positive or negative 111In-ibritumomab findings before therapy.